Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by August 31?
Measles cases in U.S. by August 31?
NOWE
Aug 31, 2026
2400+
98%
2450+
92%
2500+
82%
2550+
53%
2600+
56%
$647 Wol.
2400+
$482 Wol.
98%
2450+
$125 Wol.
92%
2500+
$0 Wol.
82%
2550+
$29 Wol.
53%
2600+
$10 Wol.
56%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Jul 31, 2026, 10:25 AM ET
Wolumen
$647Data zakończenia
Aug 31, 2026Rynek otwarty
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$647Data zakończenia
Aug 31, 2026Rynek otwarty
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania